Birmingham to lead ground-breaking research into patient experience of cell therapies

Birmingham health researchers, with industry partners including health technology companies Dignio and Datatrial, have been awarded £1.1 million by UK Research & Innovation (UKRI)’s Innovate UK, to investigate patients’ experience of cell and gene therapies. The funding has been provided as part of the Industrial Strategy Challenge Fund’s Medicines Manufacturing programme. Cell and gene therapies … Continue reading “Birmingham to lead ground-breaking research into patient experience of cell therapies”

BHP founder member becomes part of the National NIHR BioResource network

The Centre for Rare Diseases at the Queen Elizabeth Hospital Birmingham, part of the BHP campus, has this week become part of the NIHR (National Institute for Health Research) BioResource network. The BioResource team at will be led by Dr Graham Lipkin while Humeira Hafsa, research nurse, will take on the role of Clinical Trials … Continue reading “BHP founder member becomes part of the National NIHR BioResource network”

Team effort keeps blood trial on track

BHP-led RePHILL (REsuscitation with Pre-HospItaL bLood products) is the UK’s first trial in which eligible patients are recruited by ‘pre-hospital emergency medical (PHEM) teams’ and are randomly allocated treatment with either pre-hospital blood products or the standard care, saline. The RePHILL trial assesses the effects of giving trauma patients blood products after a major injury, … Continue reading “Team effort keeps blood trial on track”

UHB are double winners at CRN awards

Thomas Pinkney and Linda Webber, both based at founder member University Hospitals Birmingham NHS Foundation Trust (UHB), were winners at the NIHR Clinical Research Network West Midlands (CRNWM) third annual awards. The other UHB nominations, which included the Paediatric Research and Cystic Fibrosis Research teams at Heartlands Hospital and the Peri-Operative Research team at the … Continue reading “UHB are double winners at CRN awards”

Epidural use could be halved by patient-controlled drug

A trial co-ordinated by founder members the University of Birmingham has identified a more effective pain relieving drug for women in labour, which could significantly reduce the number of women requiring an epidural. In the RESPITE trial, researchers at the Universities of Birmingham, Sheffield and Nottingham, compared two drugs given for pain control in labour … Continue reading “Epidural use could be halved by patient-controlled drug”